Notes and sources / open the record
Use the links below to check a doctor or pharmacy, find FDA approval information, or learn whether a payment program fits your care.
Read the record for the full name supplied to you.
Doctor status, medical registrations and public board actions.
The nursing board’s route to its public records.
Start at the official board page and follow its licence search.
The medical board’s account of the state telehealth duties.
These Alabama searches are free. Use the medical board search for a doctor, physician assistant or nurse practitioner, the nursing search for a nurse, and the pharmacy search for a pharmacy.
The Food and Drug Administration (FDA) checks medicines before granting US approval. Look up the precise product name and check its form: tablet, shot or something else.
Search the medicine name in Drugs@FDA to find approved products and what they are approved to treat.
Why medicines are made to order and why FDA has not approved those medicines.
How the end of a national shortage changes the rules for making copies of ready-made medicines.
The board’s stated position on clinician involvement.
Approved products include Ozempic and Wegovy (semaglutide) as well as Mounjaro and Zepbound (tirzepatide). Their injection products were absent from FDA’s national shortage list on September 26, 2026.
Take your product and prescribed use to the plan or program.
Medicare program
The Medicare GLP-1 Bridge has a July 1, 2026 start date and a December 31, 2027 end date. Qualifying members pay $50 per month for certain weight medicines. That payment does not reduce their Part D deductible or count toward the yearly limit on what they pay for covered drugs.
Ask the prescriber whether you, your plan and your exact medicine meet the program’s rules. The insurance note explains the main checks and the $50 payment.
Keep the product label, care records and a clear account of what happened.
The route for a complaint about a doctor or physician assistant.
The route for a nurse’s nursing care.
The route for pharmacy practice concerns.
The route for a concern about misleading business conduct.
The route for reporting a medical product problem.
As of October 1, 2026, Alabama’s medical board asks for completed original complaint forms returned using its form instructions.
Alabama’s pharmacy board cannot handle customer-service complaints or disputes about prices or bills.
Keep going
Put the answers on the print sheet